CANNect Group

05/11/2021

Our Director of Operations at eCS Clinic, Dr. Carrie Newbold, will be participating in the Australian Cannabis Summit in Brisbane on November 26th-27th 2021. This is the first event of its kind and is free to watch! This event will bring some of the world's most respected minds on cannabis to your phone or computer screen!

Dr. Newbold will be discussing the Endocannabinoid System (ECS), its interaction with phytocannabinoids, and how/when to prescribe them. This will be valuable knowledge for doctors interested in prescribing cannabinoid medications to their patients.

Speaker bio and details for Dr Carrie Newbold

05/10/2021

Like many great discoveries in medicine, it started with an ‘Aha’ moment when Canadian physician Dr. Vincent Maida realised that leg ulcers could be penetrated by fat-loving cannabis compounds, which in turn could reach the plethora of cannabinoid receptors below.

Very few people are more committed to finding a better solution for wound management than Dr. Maida, who amongst other things runs a tertiary wound clinic caring for the most hard-to-heal leg ulcers in the greater Toronto area.

“Integument [the outside skin, cutaneous membranes and mucous membranes] and wound is the area of healthcare with the worst outcome measures,” explains Maida. “And yet, when you look at the massive expenditures – the United States spends upwards of $80 billion a year on wounds. And most of that I can submit to you is in vain and is just silly dressings that do nothing.”

Topical cannabis: A pioneering approach to wound healing.

21/09/2021

Public consultations are now OPEN on proposed amendments to the Poisons Standard. At the present moment, cannabinoid medications (THC/CBD) within Schedule 8 are only available for therapeutic use on humans and we believe this needs to change.

This is your chance to have your voice heard. Let’s improve the medical system for animals under veterinary care. Your pets deserve it!

All submissions received by 7 October, 2021 will be considered by the delegate before they make an interim decision.

Instructions:

1. Follow the link provided below, read and select ‘continue’

2. On the next page read how to respond, then select ‘continue’

3. Accept the Government’s privacy policy, then select ‘continue’

4. Fill out the required information!

If you have any questions at all, please reach out to us on social media or email: info@cannectvet.com

The site lists consultations that are run by the Department of Health and Ageing. On this site you can find, share or take part in consultations.

20/09/2021

MONASH University Accident Research Centre

Do you have a license to drive in Australia, or have you held one in the past two years? Have you taken cannabis for medicinal purposes in the last two years? If so, we would like to hear from you.

Monash University Accident Research Centre is looking for participants who take medicinal cannabis, including cannabinoid medications such as CBD and THC: CBD, to complete an online survey to find out how and why they take it, and their attitudes and behaviours towards driving after taking these medications.

The survey should take 20-35 minutes to complete and will be open until February 2022.

The research has been approved by the Monash University Human Research Ethics Committee, Project ID: 27156.

The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.

19/09/2021

We would like to welcome Dr. Zhou from Vogue Medical as CANNect Group's newest practitioner. Dr. Zhou is now set up and prescribing medicinal cannabinoids to patients.

24/08/2021

CANNect Group Lodges Submission to Amend Schedule 8 of the Poisons Standard (the SUSMP) and is asking for the public's help.

Beginning some time in the next week, we are asking for your support to allow veterinarians to access medicinal cannabis treatments. This is an invaluable change for veterinarians, pet owners and their furry family members.

“It is a welfare issue for animals not being able to access medicinal cannabis. I know at the moment many vets may be afraid because they don’t have the knowledge, but that’s what we’re here for, to educate and support.”
- Dr. Marta Calvo Blanco

Cannect Group is asking the public to add feedback to their TGA application focused on rewording cannabis products to allow for veterinary access.

19/08/2021

CANNect Group has been nominated for the 2022 Australian Financial Review AFR Boss Best Places To Work List!

We are so grateful for this opportunity! Thank-you to all our frontline staff, doctor's, pharmacists, and scientists! Your tireless efforts do not go unnoticed!

In today’s rapidly changing world, we need to develop workplaces that foster adaptability and agility. Successful organisations have staff who are productive, creative, and focussed in the face of endless digital distractions, and those who are pioneering best-practices in areas such as wellbeing, flexibility and equality.

The AFR BOSS Best Places to Work recognises companies based in Australia and New Zealand who are able to do exactly this. These prestigious awards are underpinned by rigorous scientifically-proven methodology provided by leading behavioural science consultancy, Inventium.

To learn more, visit:
https://afrbestplacestowork.com/

12/08/2021

CANNect Group needs your support at the end of August to allow Veterinarians to administer new medicines to pets. More information to follow!

In the last few days, CANNect Veterinary has lodged a submission for a proposed amendment to Schedule 8 (S8) of the Poisons Standard. This will become open to public consultation this August and will last for 1 month.

This amendment involves rewording Schedule 8 of Cannabis and Tetrahydrocannabinols to make these medications available to animals under veterinary control. This is an invaluable change for veterinarians, pet owners and their furry family members.

In the coming weeks we will be inviting you, as a veterinarian or pet owner, to support our application for the rescheduling of these medicines. We will be sharing with you why this change is important and instructions on how to make your voice count! This is your chance to create a positive change in Australia by helping animals to have access to a whole range of new medicines that are beneficial for them.

Please feel free to contact CANNect Veterinary for more information: info@cannectvet.com

15/07/2021

The Royal Australian College of General Practitioners (RACGP) highlights the need for further high-quality research into the safety and effectiveness of medicinal cannabis products, as the current evidence is limited and inconclusive.

The current available evidence does, however, suggest a possible role for medicinal cannabis products in a number of areas. Therefore, if after conventional, evidence-based treatments have failed, and the specialist general practitioner (GP) feels that medicinal cannabis products are a viable treatment option for their patients, they should, as other specialists can, be able to prescribe appropriate medicinal cannabis products in accordance with the current regulatory framework.

Please feel free to review the summary of evidence on medicinal cannabis products

GPs are faced with the pressing need to help patients manage chronic and debilitating conditions, with chronic pain affecting approximately one in five people

08/07/2021

Our team making waves at ANCP 2021 and GPCE 2021. There is interest in the services CANNect is offering to patients and medical professionals.